Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart

Charlotte Gredal; Anne Mette Rosenfalck; Anders Dejgaard; Jannik Hilsted

doi:10.1080/00365510802207982

Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart

Charlotte Gredal, Anne Mette Rosenfalck, Anders Dejgaard, Jannik Hilsted

Management and administration

3 Citations (Scopus)

Abstract

To assess the effect of substitution of early insulin release with a small weight-based dose of the rapid acting insulin analogue, insulin Aspart (IAsp), on postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes.

Original language	English
Journal	Scandinavian Journal of Clinical & Laboratory Investigation
Volume	68
Issue number	8
Pages (from-to)	739-44
Number of pages	6
ISSN	0036-5513
DOIs	https://doi.org/10.1080/00365510802207982
Publication status	Published - 2008

Keywords

Blood Glucose
Body Weight
Diabetes Mellitus, Type 2
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Hyperglycemia
Injections, Subcutaneous
Insulin
Insulin Aspart
Male
Middle Aged
Placebos

Access to Document

10.1080/00365510802207982

Cite this

Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart. / Gredal, Charlotte; Rosenfalck, Anne Mette; Dejgaard, Anders et al.
In: Scandinavian Journal of Clinical & Laboratory Investigation, Vol. 68, No. 8, 2008, p. 739-44.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{3afe30f7204c4ea9bd3ea5f4dbd5cf77,

title = "Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart",

abstract = "To assess the effect of substitution of early insulin release with a small weight-based dose of the rapid acting insulin analogue, insulin Aspart (IAsp), on postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes.",

keywords = "Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Hyperglycemia, Injections, Subcutaneous, Insulin, Insulin Aspart, Male, Middle Aged, Placebos",

author = "Charlotte Gredal and Rosenfalck, {Anne Mette} and Anders Dejgaard and Jannik Hilsted",

year = "2008",

doi = "10.1080/00365510802207982",

language = "English",

volume = "68",

pages = "739--44",

journal = "Scandinavian Journal of Clinical & Laboratory Investigation",

issn = "0036-5513",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart

AU - Gredal, Charlotte

AU - Rosenfalck, Anne Mette

AU - Dejgaard, Anders

AU - Hilsted, Jannik

PY - 2008

Y1 - 2008

N2 - To assess the effect of substitution of early insulin release with a small weight-based dose of the rapid acting insulin analogue, insulin Aspart (IAsp), on postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes.

AB - To assess the effect of substitution of early insulin release with a small weight-based dose of the rapid acting insulin analogue, insulin Aspart (IAsp), on postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes.

KW - Blood Glucose

KW - Body Weight

KW - Diabetes Mellitus, Type 2

KW - Dose-Response Relationship, Drug

KW - Drug Administration Schedule

KW - Female

KW - Humans

KW - Hyperglycemia

KW - Injections, Subcutaneous

KW - Insulin

KW - Insulin Aspart

KW - Male

KW - Middle Aged

KW - Placebos

U2 - 10.1080/00365510802207982

DO - 10.1080/00365510802207982

M3 - Journal article

C2 - 19016075

SN - 0036-5513

VL - 68

SP - 739

EP - 744

JO - Scandinavian Journal of Clinical & Laboratory Investigation

JF - Scandinavian Journal of Clinical & Laboratory Investigation

IS - 8

ER -

Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart

Abstract

Keywords

Access to Document

Fingerprint

Cite this